An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgery
To access this article, please choose from the options below
This review article summarizes a published evidence-based guideline. It is a product of the NASS Evidence-based Guideline Development Committee, approved by the NASS Board of Directors and accepted for publication outside The Spine Journal's peer review process.
FDA device/drug status: not applicable.
Author disclosures: CMB (royalties, Life Spine; consulting, DePuy Spine, Medtronic Sofamor Danek; speaking/teaching arrangements, DePuy Spine, Stryker Spine; board of directors, North American Spine Society; other office, Applied Spine; staff/materials, Archus Orthopedics, Synthes Spine; grants, Stryker Spine; fellowship support, DePuy Spine); WCW (consulting, Stryker; scientific advisory board, Intrinsic Therapeutics; other, Blaskstone Medical, Inc.); MHH (royalties, stock ownership, consulting, scientific advisory board, Relievant Medsystems; investigator salary, Department of Defense); DKR (consultant [NASS Spring Break], Medtronic); WOS (consulting, royalties [Upcoming Committee Meeting], DePuy Spine; trips/travel, BrainLab); PGM (stock ownership, Alkermes Corporation, Schering Plough; consulting, Synthes; speaking/teaching arrangements, AO/ASIF; grants, Medtronic).
PII: S1529-9430(09)00960-7
doi:10.1016/j.spinee.2009.09.005
© 2009 Elsevier Inc. All rights reserved.
